- Home
- BHAT vs APVO Comparison
BHAT vs APVO Comparison
Compare BHAT & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- APVO
- Stock Information
- Founded
- BHAT 2010
- APVO 2016
- Country
- BHAT China
- APVO United States
- Employees
- BHAT N/A
- APVO N/A
- Industry
- BHAT Recreational Games/Products/Toys
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- APVO Health Care
- Exchange
- BHAT Nasdaq
- APVO Nasdaq
- Market Cap
- BHAT 12.3M
- APVO 4.9M
- IPO Year
- BHAT 2019
- APVO N/A
- Fundamental
- Price
- BHAT $1.77
- APVO $1.47
- Analyst Decision
- BHAT
- APVO Strong Buy
- Analyst Count
- BHAT 0
- APVO 1
- Target Price
- BHAT N/A
- APVO $5,920.00
- AVG Volume (30 Days)
- BHAT 1.0M
- APVO 172.7K
- Earning Date
- BHAT 04-30-2025
- APVO 11-06-2025
- Dividend Yield
- BHAT N/A
- APVO N/A
- EPS Growth
- BHAT N/A
- APVO N/A
- EPS
- BHAT N/A
- APVO N/A
- Revenue
- BHAT $18,724,190.00
- APVO N/A
- Revenue This Year
- BHAT N/A
- APVO N/A
- Revenue Next Year
- BHAT N/A
- APVO N/A
- P/E Ratio
- BHAT N/A
- APVO N/A
- Revenue Growth
- BHAT N/A
- APVO N/A
- 52 Week Low
- BHAT $1.51
- APVO $1.43
- 52 Week High
- BHAT $45.00
- APVO $381.10
- Technical
- Relative Strength Index (RSI)
- BHAT 54.65
- APVO 26.96
- Support Level
- BHAT $1.62
- APVO $1.56
- Resistance Level
- BHAT $1.81
- APVO $1.73
- Average True Range (ATR)
- BHAT 0.17
- APVO 0.13
- MACD
- BHAT 0.01
- APVO 0.03
- Stochastic Oscillator
- BHAT 50.98
- APVO 6.45
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.